Controls for studies of leukaemic blasts: appropriate material and interpretation of data. by Bowen, D

The economics of morality by Bowen, D

THE RELATIONSHIP OF ARGYROPHILIC PLAQUES AND NEUROFIBRILLARY TANGLES TO THE SEVERITY OF DEMENTIA AND CORTICAL CHOLINE ACETYL TRANSFERASE LEVELS IN ALZHEIMERS-DISEASE by Wilcock, G, Esiri, M, Bowen, D

The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type. by Wilcock, G, Esiri, M, Bowen, D, Hughes, A

Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. by Wilcock, G, Esiri, M, Bowen, D, Smith, C

The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry. by Wilcock, G, Esiri, M, Bowen, D, Smith, C

Microscopy of materials: modern imaging methods using electron,x-ray and ion beams / by Bowen, D. Keith (David Keith), 1940-, Hall, C. R.

Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease. by Palmer, A, Wilcock, G, Esiri, M, Francis, P, Bowen, D

X-ray metrology in semiconductor manufacturing / by Bowen, D. Keith (David Keith), 1940-, Tanner, B. K. (Brian Keith)

Characterization of crystal growth defects by x-ray methods/ by Tanner, B. K. (Brian Keith), Bowen, D. Keith (David Keith), 1940-

NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q). by Fidler, C, Watkins, F, Bowen, D, Littlewood, T, Wainscoat, J, Boultwood, J

Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease. by Pearce, B, Palmer, A, Bowen, D, Wilcock, G, Esiri, M, Davison, A

Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy. by Bowen, D, Procter, A, Mann, D, Snowden, J, Esiri, M, Neary, D, Francis, P

High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation by Liberante, F, Pellagatti, A, Boncheva, V, Bowen, D, Mills, K, Boultwood, J, Guinn, B

Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type. by Appleyard, M, Smith, A, Berman, P, Wilcock, G, Esiri, M, Neary, D, Bowen, D

High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation. by Liberante, F, Pellagatti, A, Boncheva, V, Bowen, D, Mills, K, Boultwood, J, Guinn, B

Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment. by Francis, P, Palmer, A, Sims, N, Bowen, D, Davison, A, Esiri, M, Neary, D, Snowden, J, Wilcock, G

Lenalidomide monotherapy and in combination with cytarabine, daunorubicin and etoposide for high-risk myelodysplasia and acute myeloid leukaemia with chromosome 5 abnormalities. by Dennis, M, Culligan, D, Karamitros, D, Vyas, P, Johnson, P, Russell, N, Cavenagh, J, Szubert, A, Hartley, S, Brown, J, Bowen, D

Oligonucleotide microarray analysis of CD34+cells in patients with low risk myelodysplasia and age-matched healthy subjects. by Sternberg, A, Ahmed, M, Johnson, S, Killick, S, Bowen, D, Chapman, C, Vadher, B, Girish, R, Vassilou, G, Freeman, T, Seidl, T, Bruno, L, Vyas, P

The presence of a FLT3 mutation in AML adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Analysis of 854 patients fro... by Kottaridis, P, Gale, R, Frew, M, Harrison, G, Langabeer, SE, Belton, A, Walker, H, Wheatley, K, Bowen, D, Burnett, A, Goldstone, A, Linch, D